News, trends, and stories from the synthetic biology industry

Hi all,

Congratulations to Jennifer Doudna and Emmanuelle Charpentier for sharing the 2020 Nobel chemistry prize! Many genome editors existed before CRISPR, but CRISPR is the first editor that allows researchers to alter several genes in the same experiment, with remarkable ease and speed. The award smashed records and made scientific history as the only science Nobel ever won by two women, according to STAT.

“I know so many wonderful scientists who will never receive this, for reasons that have nothing to do with the fact that they are wonderful scientists,” said Doudna in an article for Nature News. “I am really kind of humbled.”

Emmanuelle Charpentier and Jennifer Doudna.


What if you had a tool to change the genetic instructions that cause disease? That's what San Francisco-based Scribe Therapeutics hopes to do with its next-generation platform for gene editing. The company, co-founded by Benjamin Oakes, David Savage, Brett Stahl, and CRISPR co-inventor Jennifer Doudna, received an initial $20 million in funding from Andressen Horowitz. Scribe just announced a collaboration with Biogen to develop CRISPR-based genetic medicines for neurological diseases, including Amyotrophic Lateral Sclerosis (ALS).

Jennifer Doudna is the Co-founder of Scribe Therapeutics, a new company developing CRISPR-based genetic medicines. She recently received the SynBioBeta Award “Pioneer in Synthetic Biology” at SynBioBeta 2020.

This World Food Day (October 16th), coming to screens everywhere: Thought For Food, the 2020 Challenge Finale, is a 3-hour live broadcast that tells the stories of purpose-driven entrepreneurs at the frontlines of food system transformation. Be a part of it.

You’ve heard of computer-aided design. What about computer-aided biology? “Synthetic biology is the future of biology,” says Hermann Hauser, “but biology needs standardized lab procedures to produce replicable results the way microprocessors standardized instruction sets for programming. This will make it possible to program biology.”

A new approach to a deadly breast cancer offers hope to the black women it affects most. Dr. Karmella Haynes is tackling resistant triple-negative breast cancer through chromatin engineering. As this cancer type disproportionately affects Black women, Haynes seeks to improve health outcomes for medically underserved patients.

Could a Chief Biology Officer make your company more profitable? Your Chief Biology Officer will help you make sense of the impact of biotechnology on your business, identify vendors that use sustainable biological manufacturing, secure supply chains, and completely transform your business.

In funding news:

COVID-19 News

Latest News

Machine learning and synthetic biology used to optimize a cellular factory for industrially relevant products (Press release)

The battle to save the world’s rarest species from extinction following Mauritius oil spill (Forbes)

Skretting partners with Chevron-backed alternative feed ingredient supplier, NovoNutrients (IntraFish)

Microbes can be the key to curbing nitrogen pollution (CleanTechnica)

Riffyn and Imperial College to build digital foundations to accelerate synthetic biology research (Press release)

Modern Meadow scaling up from Culture Bioscience’s 250ml reactors to 5,000L tanks

Motif FoodWorks preps commercial production for its first ingredient (TechCrunch)

Biosynthesis of cannabinoids: Vanguard of the bio revolution (Raymond James)

Sandia helps safeguard biological data threatened during Covid-19 pandemic (Press release)

Black & Veatch ‘Experts on Demand’ service to offer food & beverage, biotechnology and bioenergy expertise (Press release)

Senate Democrats unveil the America LEADS Act to make comprehensive investments in American workers

OriCiro launches world’s first cell-free amplification technology for large circular DNA (Press release)

Ansa Biotechnologies partners with TeselaGen Biotechnology to enable commercial production of DNA products (Press release)

IDT expands global footprint with launch of IDT China (Press release)

Moderna and Vertex establish new collaboration to treat cystic fibrosis using gene editing (Press release)

Amyris delivering sustainable alternative to shark squalene adjuvant – enabling vaccines for all with no sharks killed (Press release)

Genomatica named finalist in Chemical Week 's first-ever Sustainability Awards

A new aquaculture vaccine development company has been launched by Touchlight Genetics and Stonehaven Incubate (The Fish Site)

The Patentability of Synthetic Biology Inventions (Springer)

A conversation with Matthias Berninger, Head of Public Affairs, Science, and Sustainability at Bayer (Bioeconomy.XYZ)

The Review and Revision of the Screening Framework Guidance for Providers of Synthetic Double-Stranded DNA is open for comment until October 25

ADM and Spiber to partner on production of innovative biobased polymers (Press release)

Who's hiring?

Scientist: Palamedrix – San Diego, CA
 

Molecular Biology Team Lead: Slone Partners – San Carlos, CA

 

COVID Test Processor: OpenCell – Jersey, UK

 

Biochip Design Engineer: Analog Devices – Boston, MA

 

Postdoctoral fellow: GartonLab – Toronto, Canada

 

Sr. Scientist/Principal Scientist, HTP Cloning & Protein Expression: AbSci – Vancouver, WA

 

Senior Scientist, Strain Engineering: AbSci – Vancouver, WA

 

Scientist, NGS Data Analysis: AbSci – Vancouver, WA

 

Scientist, HTP Cloning & Protein Expression: AbSci – Vancouver, WA

 

Research Associate/Sr. Research Associate – Cloning: AbSci – Vancouver, WA

 

Group Leader, Purification: AbSci – Vancouver, WA

 

Technical Program Manager: AbSci – Vancouver, WA

 

Research Associate, High-throughput Screening: AbSci – Vancouver, WA

 

Director/Senior Director, Business Development: AbSci – Remote, US

 

Director/Senior Director, Business Development: AbSci – Boston, MA

 

Software Developer, Full-Stack or Front-End: AbSci – Vancouver, WA

 

Scientist, Analytical Development: AbSci – Vancouver, WA

 

Postdoctoral Research Fellow (Gene Delivery): John A. Burns School of Medicine – Honolulu, HI

 

Scientist, Synthetic Biology: Empress Therapeutics, Inc. – Cambridge, MA

 

Sr/Principal Scientist, Gene Therapy & AAV Engineering: Codexis – Redwood City, CA

 

Scientist, Molecular Biology – Cell Biology: Codexis – Redwood City, CA

 

Scientist, Molecular Biology – Cell Biology: Codexis – Redwood City, CA

 

Scientist, Molecular Biology: Codexis – Redwood City, CA

 

Scientist, Bioprocess Development – Downstream: Codexis – Redwood City, CA

 

Research Assistant/Associate, Biotherapeutics Lead Discovery: Codexis – Redwood City, CA

 

Research Assistant/Associate, Biochemistry: Codexis – Redwood City, CA

Research Assistant, Molecular Biology: Codexis – Redwood City, CA

 

Quality Control Lead: Codexis – Redwood City, CA

 

Product Manager, NGS: Codexis – Redwood City, CA

 

Patent Attorney: Codexis – Redwood City, CA

 

IT Accounting System Administrator: Codexis – Redwood City, CA

 

Facilities Technician & Material Handler: Codexis – Redwood City, CA

 

Bioprocess Development Associate – Downstream: Codexis – Redwood City, CA

 

Associate Director, Alliance Management for Performance Enzyme Business: Codexis – Redwood City, CA

 

Senior Director of Data Science – Applications Development: Inscripta – Fully Remote

 

Director of Applications Development – Synthetic Biology: Inscripta – Boulder, CO

 

Account Executive: Inscripta – DACH, EMEA

 

Research Scientist: Colorifix – Norwich Research Park, Norwich

 

Senior Process Engineer: Inscripta – San Diego, CA

 

Senior Instrument Control Software Engineer: Inscripta – Pleasanton, CA

 

Field Service Engineer (FSE): Inscripta – Europe

 

Technical Informatics Specialist (TIS): Inscripta – Boulder, CO

 

Account Executive: Inscripta – Midwest, US

 

Data Scientist: Inscripta – Remote Worker

 

Staff Scientist (Enzyme Engineering): Inscripta – Pleasanton, CA

 

Technology Development Engineer/Scientist: Inscripta – Boulder, CO

 

Senior Scientist, Biochemistry: Inscripta – Pleasanton, CA

 

Computational Biology Scientist: Inscripta – Boulder, CO

 

Field Applications Scientist – East: Inscripta, Boston,MA

 

Feature your job here